Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre‐synaptic muscarinic receptor activation from rat striatal synaptosomes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Neurochemistry

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1471-4159.2007.04562.xPMID 17437547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased Subunit Stability as a Novel Mechanism for Potassium Current Impairment by a KCNQ2 C Terminus Mutation Causing Benign Familial Neonatal Convulsions*

  2006cited by this paper
• The KCNQ Channel Opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat

  2006cited by this paper
• A Common Ankyrin-G-Based Mechanism Retains KCNQ and NaV Channels at Electrically Active Domains of the Axon

  2006cited by this paper
• Retigabine: chemical synthesis to clinical application.

  2006cited by this paper
• Pathways modulating neural KCNQ/M (Kv7) potassium channels

  2005cited by this paper
• Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels

  2005cited by this paper
• Ion Channels

  2005cited by this paper
• Meclofenamic Acid and Diclofenac, Novel Templates of KCNQ2/Q3 Potassium Channel Openers, Depress Cortical Neuron Activity and Exhibit Anticonvulsant Properties

  2005cited by this paper
• Cholinergic Suppression of KCNQ Channel Currents Enhances Excitability of Striatal Medium Spiny Neurons

  2005influential reference
• KCNQ2 Is a Nodal K+ Channel

  2004cited by this paper
• M Channels Containing KCNQ2 Subunits Modulate Norepinephrine, Aspartate, and GABA Release from Hippocampal Nerve Terminals

  2004influential reference
• Presynaptic K+ channels: electrifying regulators of synaptic terminal excitability.

  2004cited by this paper
• Dihydropiridines Mechanism of Action in Striatal Isolated Nerve Endings: Comparison with ω-Agatoxin IVA

  2004cited by this paper
• A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation

  2004cited by this paper
• Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications.

  2004influential reference
• Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia

  2003cited by this paper
• Activation of M1 Muscarinic Receptors Triggers Transmitter Release from Rat Sympathetic Neurons Through an Inhibition of M‐Type K+ Channels

  2003cited by this paper
• The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain.

  2003cited by this paper
• KCNQ/M Currents in Sensory Neurons: Significance for Pain Therapy

  2003cited by this paper
• Activation of muscarinic m5 receptors inhibits recombinant KCNQ2/KCNQ3 K+ channels expressed in HEK293T cells.

  2003cited by this paper
• Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission.

  2002cited by this paper
• The Inhibition of Glutamate Release by Metabotropic Glutamate Receptor 7 Affects Both [Ca2+] c and cAMP

  2002influential reference
• Calmodulin Is an Auxiliary Subunit of KCNQ2/3 Potassium Channels

  2002cited by this paper
• Molecular correlates of the M‐current in cultured rat hippocampal neurons

  2002influential reference
• Multiple Muscarinic Acetylcholine Receptor Subtypes Modulate Striatal Dopamine Release, as Studied with M1–M5 Muscarinic Receptor Knock-Out Mice

  2002influential reference
• The Inhibition of Glutamate Release by Metabotropic Glutamate Receptor 7 Affects Both [Ca 2 (cid:1) ] c and cAMP EVIDENCE FOR A STRONG REDUCTION OF Ca 2 (cid:1) ENTRY IN SINGLE NERVE TERMINALS*

  2002influential reference
• M Channel KCNQ2 Subunits Are Localized to Key Sites for Control of Neuronal Network Oscillations and Synchronization in Mouse Brain

  2001influential reference
• Therapeutic opportunities from muscarinic receptor research.

  2001cited by this paper
• Inhibition of acetylcholine muscarinic M1 receptor function by the M1‐selective ligand muscarinic toxin 7 (MT‐7)

  2000cited by this paper
• Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy.

  2000cited by this paper
• Entrapping of Impermeant Probes of Different Size into Nonpermeabilized Synaptosomes as a Method to Study Presynaptic Mechanisms

  2000cited by this paper
• The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.

  2000influential reference
• Muscarinic-induced modulation of potassium conductances is unchanged in mouse hippocampal pyramidal cells that lack functional M1 receptors.

  2000cited by this paper
• Synaptosomes Still Viable after 25 Years of Superfusion

  2000influential reference
• Neuronal KCNQ potassium channels:physislogy and role in disease

  2000cited by this paper
• Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.

  2000influential reference
• Potassium channels: molecular defects, diseases, and therapeutic opportunities.

  2000cited by this paper
• Differential tetraethylammonium sensitivity of KCNQ1–4 potassium channels

  2000cited by this paper
• Modulation and genetic identification of the M channel.

  2000cited by this paper
• Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.

  2000cited by this paper
• K+‐evoked [3H]D‐aspartate release in rat spinal cord synaptosomes: Modulation by neuropeptide Y and calcium channel antagonists

  2000cited by this paper
• KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy.

  2000cited by this paper
• Ion channels in presynaptic nerve terminals and control of transmitter release.

  1999cited by this paper
• Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels

  1999cited by this paper
• Modulation of Spontaneous and Stimulation‐Evoked Transmitter Release from Rat Sympathetic Neurons by the Cognition Enhancer Linopirdine: Insights into Its Mechanisms of Action

  1999cited by this paper
• International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

  1998cited by this paper
• Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine.

  1998cited by this paper
• KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

  1998influential reference
• Workshop: the use of muscarinic toxins in the study of muscarinic receptors.

  1997cited by this paper
• Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice.

  1997cited by this paper
• Control of M-current.

  1997cited by this paper
• D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

  1996cited by this paper
• Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions.

  1994cited by this paper
• Nicotinic Modulation of [3H]Dopamine Release from Striatal Synaptosomes: Pharmacological Characterisation

  1990cited by this paper
• Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.

  1989cited by this paper
• Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine.

  1985influential reference
• Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines.

  1984cited by this paper
• Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine.

  1982cited by this paper
• Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quashi-physiological" depolarization.

  1982cited by this paper
• Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone

  1980cited by this paper
• INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

  1976cited by this paper
• B. TYROSINE HYDROXYLASE

  1966cited by this paper

• Kv7 channel opener retigabine reduces self‐administration of cocaine but not sucrose in rats

  2024cites this paper
• Activation of Kv7 channels normalizes hyperactivity of the VTA-NAcLat circuit and attenuates methamphetamine-induced conditioned place preference and sensitization in mice

  2023cites this paper
• Handbook of Ion Channels

  2023cites this paper
• Kv7 Channel Opener Retigabine Reduces Self-Administration of Cocaine but Not Sucrose in Rats

  2023cites this paper
• Central Lancashire Online Knowledge (CLoK)

  2023influential citation
• Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment

  2023influential citation
• Perspectives of Presynaptic Autoreceptors and Presynaptic Heteroreceptors in the Mechanism of Neurotransmission

  2022cites this paper
• KCNQ3 normalizes hyperactivity of VTA-NAcLat circuit and attenuates methamphetamine addiction in mice

  2022cites this paper
• The Dopamine System: Insights between Kidney and Brain

  2022cites this paper
• The Role of NEDD4 E3 Ubiquitin–Protein Ligases in Parkinson’s Disease

  2022cites this paper
• Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease

  2022cites this paper
• Flexible Stoichiometry: Implications for KCNQ2- and KCNQ3-Associated Neurodevelopmental Disorders

  2021cites this paper
• ATP-sensitive potassium channel subunits in the neuroinflammation: novel drug targets in neurodegenerative disorders.

  2021cites this paper
• Identification of potassium channel proteins Kv7.2/7.3 as common partners of the dopamine and glutamate transporters DAT and GLT-1.

  2019cites this paper
• Alterations in Ion Channel Expression Surrounding Implanted Microelectrode Arrays in the Brain

  2019cites this paper
• Inhibition of striatal cholinergic interneuron activity by the Kv7 opener retigabine and the nonsteroidal anti‐inflammatory drug diclofenac

  2018cites this paper
• Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents

  2018cites this paper
• The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.

  2018cites this paper
• The pan‐Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo

  2017cites this paper
• Potassium Channels: A Potential Therapeutic Target for Parkinson’s Disease

  2017cites this paper
• IDENTIFICATION OF NOVEL PATHOGENETIC MECHANISMS , GENOTYPE-PHENOTYPE CORRELATIONS AND PHARMACOLOGICAL APPROACHES IN EARLY-ONSET EPILEPSIES

  2017cites this paper
• The Role of KV7.3 in Regulating Osteoblast Maturation and Mineralization

  2016cites this paper
• Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption

  2016cites this paper
• A disfunção dopaminérgica mesolímbica na psicose: uma revisão da literatura

  2015cites this paper
• Protective Role of Kv7 Channels in Oxygen and Glucose Deprivation-Induced Damage in Rat Caudate Brain Slices

  2015cites this paper
• Kv7 Potassium Channels Driving With No Brakes: Molecular Pathophysiology of

  2015cites this paper
• The Kv7 potassium channel activator retigabine decreases alcohol consumption in rats

  2014cites this paper
• Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels

  2013cites this paper
• Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors.

  2012cites this paper
• Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.

  2012cites this paper
• Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro.

  2012cites this paper
• Functional role of M‐type (KCNQ) K+ channels in adrenergic control of cardiomyocyte contraction rate by sympathetic neurons

  2011cites this paper
• The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.

  2011cites this paper
• Novel Medications for Epilepsy

  2011cites this paper
• Role of neuronal potassium M‐channels in sympathetic regulation of cardiac function

  2011influential citation
• Driving with no brakes: molecular pathophysiology of Kv7 potassium channels.

  2011cites this paper
• Epileptic Channelopathies and Dysfunctional Excitability - From Gene Mutations to Novel Treatments

  2011influential citation
• KV7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus

  2011cites this paper
• Novel Aspects on Epilepsy

  2011cites this paper
• Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampus

  2011cites this paper
• ON THE MECHANISM OF ACTION OF THE NON-OPIOID ANALGESIC FLUPIRTINE

  2011cites this paper
• Maurizio Taglialatela Kv 7 Potassium Channels Driving With No Brakes : Molecular Pathophysiology of

  2011cites this paper
• Facilitation of transmitter release from rat sympathetic neurons via presynaptic P2Y1 receptors

  2011cites this paper
• Regulation of Neuronal M-Channel Gating in an Isoform-Specific Manner: Functional Interplay between Calmodulin and Syntaxin 1A

  2011cites this paper
• A Molecular Mechanism for Endocytic Recycling of the M5 Muscarinic Acetylcholine Receptor

  2010influential citation
• Pre‐synaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals

  2010cites this paper
• AGAP1/AP‐3‐dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release

  2010cites this paper
• DERIVATION, ENRICHMENT AND CHARACTERIZATION OF DOPAMINERGIC NEURONS FROM PLURIPOTENT STEM CELLS

  2010cites this paper
• The Acrylamide (S)-2 As a Positive and Negative Modulator of Kv7 Channels Expressed in Xenopus laevis Oocytes

  2009cites this paper
• Selective Interaction of Syntaxin 1A with KCNQ2: Possible Implications for Specific Modulation of Presynaptic Activity

  2009cites this paper
• Enhancing M Currents: A Way Out for Neuropathic Pain?

  2009cites this paper
• Antipsychotic-Like Effect of Retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic Acid Ester], a KCNQ Potassium Channel Opener, via Modulation of Mesolimbic Dopaminergic Neurotransmission

  2009cites this paper
• Activation of pre‐synaptic M‐type K+ channels inhibits [3H]d‐aspartate release by reducing Ca2+ entry through P/Q‐type voltage‐gated Ca2+channels

  2009cites this paper
• Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.

  2009cites this paper
• Inhibition of transmitter release from rat sympathetic neurons via presynaptic M1 muscarinic acetylcholine receptors

  2009cites this paper
• A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions.

  2009cites this paper
• Facilitation of transmitter release from rat sympathetic neurons via presynaptic P2Y1 receptors

  2008cites this paper
• A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels

  2008cites this paper
• Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.

  2008cites this paper
• Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS

  2008influential citation